n,n-dimethylarginine has been researched along with Erectile Dysfunction in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 7 (63.64) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azevedo, AMM; Brites-Anselmi, G; Coeli-Lacchini, FB; de Almeida Belo, V; de Andrade, MF; Hirsch, E; Lacchini, R; Molina, CAF; Pinheiro, LC; Tanus-Santos, JE; Tucci, S | 1 |
Hotta, Y; Kataoka, T; Kimura, K; Maeda, Y | 1 |
Fu, Q; Hu, LL; Tian, T; Zhang, H; Zhang, KQ | 1 |
Chen, Z; Cui, K; Liu, J; Luan, Y; Rao, K; Tang, Z; Wang, D; Wang, S; Wang, T | 1 |
Atabey, N; Demir, O; Demir, T; Durmus, N; Esen, A; Evcim, S; Gidener, S; Irer, B; Kahraman, E; Soner, BC; Toylu, A | 1 |
Dugina, JL; Epstein, OI; Gamidov, SI; Mazo, EB; Sergeeva, SA; Tarasov, SA; Zhavbert, ES | 1 |
Gamidov, SI; Gasanov, RV; Mazo, EB; Sotnikova, EM | 1 |
Aktoz, M; Aktoz, T; Altun, A; Atakan, IH; Barutcu, A; Demir, M; Kaplan, M; Tatlı, E; Turan, FN | 1 |
Barassi, A; Ciociola, F; Colpi, GM; Corsi, MM; Dozio, E; Fermo, I; Finati, E; Ghilardi, F; Melzi d'Eril, GV; Paroni, R | 1 |
Jackson, G; Lambert-Hammill, M; Lumb, PJ; Lyttle, K; Solomon, H; Wierzbicki, AS | 1 |
Elesber, AA; Lennon, RJ; Lerman, A; Lerman, LO; Mathew, V; McConnell, JP; Nelson, RE; Prasad, A; Pumper, G; Solomon, H | 1 |
2 trial(s) available for n,n-dimethylarginine and Erectile Dysfunction
Article | Year |
---|---|
Study of the correlation between clinical efficiency of impaza and serum ADMA level.
Topics: Adult; Antibodies; Arginine; Double-Blind Method; Erectile Dysfunction; Humans; Male; Nitric Oxide Synthase Type III | 2008 |
Prophylactics of erectile dysfunction in patients with metabolic syndrome.
Topics: Adult; Aged; Antibodies; Antihypertensive Agents; Arginine; Erectile Dysfunction; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Male; Metabolic Syndrome; Middle Aged | 2009 |
9 other study(ies) available for n,n-dimethylarginine and Erectile Dysfunction
Article | Year |
---|---|
Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: Impact on erectile dysfunction therapy.
Topics: Amidohydrolases; Arginine; Biomarkers; Erectile Dysfunction; Humans; Male; Nitrites; Phosphodiesterase 5 Inhibitors; Polymorphism, Genetic; Sildenafil Citrate | 2017 |
Testosterone Deficiency Causes Endothelial Dysfunction via Elevation of Asymmetric Dimethylarginine and Oxidative Stress in Castrated Rats.
Topics: Animals; Arginine; Castration; Endothelium; Erectile Dysfunction; Humans; Male; Nitric Oxide; Oxidative Stress; Penile Erection; Penis; Rats; Rats, Wistar; Testosterone | 2017 |
Probucol improves erectile function via Activation of Nrf2 and coordinates the HO-1 / DDAH / PPAR-γ/ eNOS pathways in streptozotocin-induced diabetic rats.
Topics: Amidohydrolases; Animals; Arginine; Blood Glucose; Body Weight; Cyclic GMP; Diabetes Mellitus, Experimental; Erectile Dysfunction; Heme Oxygenase-1; Male; Malondialdehyde; NF-E2-Related Factor 2; Nitric Oxide Synthase Type III; PPAR gamma; Probucol; Rats, Sprague-Dawley; Signal Transduction; Streptozocin; Superoxide Dismutase | 2018 |
Involvement of DDAH/ADMA/NOS/cGMP and COX-2/PTGIS/cAMP Pathways in Human Tissue Kallikrein 1 Protecting Erectile Function in Aged Rats.
Topics: Aging; Amidohydrolases; Animals; Arginine; Cyclic AMP; Cyclic GMP; Cyclooxygenase 2; Cytochrome P-450 Enzyme System; Erectile Dysfunction; Humans; Intramolecular Oxidoreductases; Male; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Penile Erection; Penis; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Recombinant Proteins; RNA, Messenger; Signal Transduction; Tissue Kallikreins | 2017 |
Time-course changes of nLDL-induced erectile dysfunction.
Topics: Animals; Arginine; Disease Models, Animal; Endothelium, Vascular; Erectile Dysfunction; Hyperlipidemias; Lipoproteins, LDL; Male; Nitric Oxide Synthase Type III; Rats, Wistar; Time Factors | 2017 |
Assessment of the relationship between asymmetric dimethylarginine and severity of erectile dysfunction and coronary artery disease.
Topics: Arginine; Coronary Artery Disease; Erectile Dysfunction; Humans; Male; Middle Aged; Severity of Illness Index; Surveys and Questionnaires | 2010 |
Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction.
Topics: Adult; Arginine; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Male; Middle Aged | 2012 |
Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Arginine; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; E-Selectin; Enzyme Inhibitors; Erectile Dysfunction; Humans; Male; Middle Aged; Nitric Oxide Synthase; Piperazines; Purines; Risk Factors; Sildenafil Citrate; Sulfones | 2006 |
Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis.
Topics: Arginine; C-Reactive Protein; Coronary Artery Disease; Endothelium, Vascular; Erectile Dysfunction; Humans; Male; Middle Aged; Risk Factors | 2006 |